Shares of our common stock are listed on the NASDAQ OTC market and trade under the symbol “UEEC“.
For more information, please contact investor@uhpcorp.com
For press and media relations, please contact media@uhpcorp.com
2025 OTC Life Sciences Investor Forum
United Health Products presented at the 2025 Life Sciences Virtual Investor Forum. The full presentation is available below.
Click HERE to download the investor presentation.
Press Releases
-
United Health Products Establishes Collaboration to Conduct Clinical Study
Darien, Connecticut – July 7, 2026 – United Health Products, Inc. (OTCQB: UEEC) today announced an agreement with NAMSA, the global leader in MedTech contract research offering end-to-end development services, whereby NAMSA will serve as regulatory sponsor of a new clinical study of UHP’s CelluSTAT Hemostatic Gauze. Consistent with the company’s recent proposal to the FDA to…
-
United Health Products Provides Regulatory Update
Mount Laurel, New Jersey – April 6, 2026 – United Health Products, Inc. (OTCQB: UEEC) today provided a status update on its discussions with the Food & Drug Administration (FDA) to resolve the Warning Letter issued on March 25, 2025, identifying violations that occurred during the company’s 2019 clinical trial. Following recent discussions, the FDA earlier…
-
United Health Products Provides Corporate Update
Mount Laurel, New Jersey – December 15, 2025 – United Health Products, Inc. (OTCQB: UEEC) today provided a status update on its discussions with the Food & Drug Administration (FDA) to resolve the Warning Letter issued on March 25, 2025, identifying certain violations of required clinical procedures that occurred during the company’s 2019 clinical trial. On…
-
United Health Products to Present at the Life Sciences Virtual Investor Forum September 18th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com MT. LAUREL, N.J., Sept. 16, 2025 (GLOBE NEWSWIRE) — United Health Products (OTCQB: UEEC), focused on the development and commercialization of innovative wound care technologies, today announced that Brian Thom, Chief Executive Officer, will present live at the Life Sciences…
